(These articles have been accepted for this issue. Change is possible before publication.)
Receive this page by email each issue:
[Sign up for eTOCs]
Future Table of Contents:
Jun 1, 2008; 26 (16)
ORIGINAL REPORTS
Supportive Care and Quality of Life
-
- Rehabilitation Needs and Service Delivery in Patients With Stage IV Breast Cancer
- Andrea L. Cheville, Andrea B. Troxel, Jeffrey R. Basford, and Alice B. Kornblith
Breast Cancer
- Safety of Fertility Preservation by Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients: A Prospective Controlled Study
- Amr A. Azim, Maria Costantini-Ferrando, and Kutluk Oktay
- Estrogen Receptor Expression and Efficacy of Docetaxel-Containing Adjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: Results From a Pooled Analysis of 3,329 Patients
- Fabrice Andre, Kristine Broglio, Henri Roche, Miguel Martin, John Mackey, Frederique Penault-Llorca, Gabriel N. Hortobagyi, and Lajos Pusztai
- Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Trial
- Susan Greenspan, Adam Brufsky, Barry Lembersky, Rajib Bhattacharya, Karen Vujevich, Subashan Perera, Susan Sereika, and Victor Vogel
- Serum TIMP-1 and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen in Metastatic Breast Cancer
- Allan Lipton, Kim Leitzel, Hilary A. Chaudri-Ross, Dean Evans, Suhail M. Ali, Laurence Demers, Peter Hamer, Sheryl Brown-Shimer, Karen Pierce, Victor Gaur, and Walter Carney
Clinical Trials
- Influence of Oncologist-Patient Communication on Participation in Clinical Trials
- Terrance L. Albrecht, Susan S. Eggly, Marci E.J. Gleason, Felicity W.K. Harper, Tanina S. Foster, Amy M. Peterson, Heather Orom, Louis A. Penner, and John C. Ruckdeschel
Epidemiology
- Racial Differences in Clinical Outcomes From Metastatic Breast Cancer: A Pooled Analysis of CALGB Trials 9342 and 9840
- Blase N. Polite, Constance T. Cirrincione, Gini F. Fleming, Donald A. Berry, Andrew D. Seidman, Hyman B. Muss, Larry Norton, Charles L. Shapiro, Kamal M. Bakri, Paul Kelly Marcom, Diana Lake, Joel H. Schwartz, Clifford A. Hudis, and Eric P. Winer
Gynecologic Cancer
- Phase III Study of Valspodar Combined With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer
- Catherine Lhomme, Florence Joly, Joan L. Walker, Andrea A. Lissoni, Maria O. Nicoletto, Gregory M. Manikhas, Mark M.O. Baekelandt, Alan N. Gordon, Paula M. Fracasso, William L. Mietlowski, Gary J. Jones, and Margaret H. Dugan
- Incidence of Venous Thromboembolism in Patients With Ovarian Cancer Undergoing Platinum-Paclitaxel Containing First-Line Chemotherapy: An Exploratory Analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group
- Christina Fotopoulou, Andreas duBois, Alexandros Karavas, Ralf Trappe, Behnaz Aminossadati, Barbara Schmalfeldt, Jacobus Pfisterer, and Jalid Sehouli
Hematologic Malignancies
- Phase II Study of Dose-Adjusted EPOCH-Rituximab in Untreated Germinal Center and Post-Germinal Center Diffuse Large B-Cell Lymphoma
- Wyndham H. Wilson, Kieron Dunleavy, Stefania Pittaluga, Upendra Hegde, Nicole Grant, Seth M. Steinberg, Mark Raffeld, Martin Gutierrez, Bruce A. Chabner, Louis Staudt, Elaine S. Jaffe, and John E. Janik
- Granulocyte-Macrophage Colony-Stimulating Factor Potentiates Rituximab in Relapsed Follicular Lymphoma: Results of a Phase II Study
- Guillaume Cartron, Lu Zhao-Yang, Marion Baudard, Tarik Kanouni, Valerie Rouille, Philippe Quittet, Bernard Klein, and Jean-Francois Rossi
- Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia
- Alessandra Carobbio, Elisabetta Antonioli, Paola Guglielmelli, Alessandro M. Vannucchi, Federica Delaini, Vittoria Guerini, Guido Finazzi, Alessandro Rambaldi, and Tiziano Barbui
- Prognostic Value of Immunophenotyping of Multiple Myeloma in Patients Treated With High-Dose Therapy
- Gema Mateo, M.-Angeles Montalban, Maria-Belen Vidriales, Juan J. Lahuerta, Maria V. Mateos, Norma Gutierrez, Laura Rosinol, Laura Montejano, Joan Blade, Rafael Martinez, Javier de la Rubia, Joaquin Diaz-Mediavilla, Anna Sureda, Jose M. Ribera, Jose M. Ojanguren, Felipe de Arriba, Luis Palomera, Maria J. Terol, Alberto Orfao, and Jesus F. San Miguel
Gastrointestinal Cancer
- Phase I Trial of the HIV Protease Inhibitor Nelfinavir and Chemoradiation for Locally Advanced Pancreatic Cancer
- Thomas Brunner, Matthias Geiger, Gerhard G. Grabenbauer, Marga Lang-Welzenbach, Tine S. Mantoni, Alexander Cavallaro, Rolf Sauer, Werner Hohenberger, and W. Gillies McKenna
- Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer
- Michael S. Braun, Susan D. Richman, Philip Quirke, Catherine Daly, Julian W. Adlard, Faye Elliot, Jennifer H. Barrett, Peter Selby, Angela M. Meade, Richard J. Stephens, Mahesh K.B. Parmar, and Matthew T. Seymour
- High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma
- Xiao-Dong Zhu, Ju-Bo Zhang, Peng-Yuan Zhuang, Hong-Guang Zhu, Wei Zhang, Yu-Quan Xiong, Wei-Zhong Wu, Lu Wang, Zhao-You Tang, and Hui-Chuan Sun
Thoracic Oncology
- Specific EGFR Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non-Small-Cell Lung Cancer Receiving First-Line Gefitinib Monotherapy
- Chih-Hsin Yang, Chong-Jen Yu, Jin-Yuan Shih, Yeun-Chung Chang, Fu-Chang Hu, Meng-Chin Tsai, Kuan-Yu Chen, Zhong-Zhe Lin, Ching-Ju Huang, Chia-Tung Shun, Chin-Lun Huang, James Bean, Ann-Lii Cheng, William Pao, and Pan-Chyr Yang
Head and Neck Cancer
- Quality-of-Life Scores Predict Survival Among Patients With Head and Neck Cancer
- Carrie A. Karvonen-Gutierrez, David L. Ronis, Karen E. Fowler, Jeffrey E. Terrell, Stephen B. Gruber, and Sonia A. Duffy
REVIEW ARTICLES
- Individualizing Treatment of Patients With Myeloma in the Era of Novel Agents
- Jesus San Miguel, Jean-Luc Harousseau, Douglas Joshua, and Kenneth C. Anderson
- Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
- Bertrand Coiffier, Arnold Altman, Ching-Hon Pui, Anas Younes, and Mitchell S. Cairo
|
